SCImago Journal & Country Rank

Register your email below and receive our newsletter with news.

Continuous and bimonthly publication
ISSN (on-line): 1806-3756

Licença Creative Commons

Advanced Search

8568
Views

Back to summary

Open Access

Peer-Reviewed
Artigo Original

Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System

Diferentes modelos para avaliar a relação custo-efetividade de inibidores de tirosina quinase do EGFR no tratamento do câncer de pulmão não pequenas células metastático no contexto do Sistema Único de Saúde

Pedro Aguiar Jr1, Felipe Roitberg2, Gilberto Lopes Jr3, Auro del Giglio4

Sociedade Brasileira de Pneumologia e Tisiologia

Secretaria do Jornal Brasileiro de Pneumologia
SCS Quadra 01, Bloco K, Salas 203/204 Ed. Denasa
Brasília - DF CEP: 70.398-900

Fone/fax: 08000 61 6218, (61) 3245 1030 e (61) 3245 6218
E-mail: jbp@sbpt.org.br

Newsletters

Register your email below and receive our newsletter with news.
Cookie Policy

Development by:

© All rights reserved 2024 - Jornal Brasileiro de Pneumologia